Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Capital Expenditures: 2017-2021

Historic Capital Expenditures for Cogent Biosciences (COGT) over the last 3 years, with Dec 2021 value amounting to $433,000.

  • Cogent Biosciences' Capital Expenditures was N/A to $433,000 in Q4 2021 from the same period last year, while for Dec 2021 it was $1.6 million, marking a year-over-year change of. This contributed to the annual value of $573,000 for FY2024, which is 79.51% down from last year.
  • Latest data reveals that Cogent Biosciences reported Capital Expenditures of $433,000 as of Q4 2021, which was down 62.77% from $1.2 million recorded in Q3 2021.
  • In the past 5 years, Cogent Biosciences' Capital Expenditures registered a high of $1.2 million during Q3 2021, and its lowest value of -$22,000 during Q3 2019.
  • Over the past 2 years, Cogent Biosciences' median Capital Expenditures value was $42,000 (recorded in 2019), while the average stood at $325,800.
  • In the last 5 years, Cogent Biosciences' Capital Expenditures spiked by 63.59% in 2018 and then tumbled by 125.58% in 2019.
  • Quarterly analysis of 4 years shows Cogent Biosciences' Capital Expenditures stood at $100,000 in 2017, then crashed by 68.73% to $86,000 in 2018, then slumped by 125.58% to $13,000 in 2019, then reached $433,000 in 2021.
  • Its last three reported values are $433,000 in Q4 2021, $1.2 million for Q3 2021, and $13,000 during Q4 2019.